Allen Nissenson, Director at Angion Biomedica Corp. (ANGN), bought 9,383 shares at $1.18 ($11K) on 2022-05-20, disclosed to the SEC on 2022-05-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.16 | 7,346 | $9K | 78.0% |
| 2 | $1.18 | 2,037 | $2K | 22.0% |
| Total | $1.16 avg | 9,383 | $11K | 100% |
| Filing → |
| DVA | SELL | 2013-05-15 | $101K | — | Filing → |
| DVA | SELL | 2013-03-08 | $300K | — | Filing → |
| DVA | SELL | 2012-11-16 | $462K | — | Filing → |